Bayesian Capital Management, LP Organogenesis Holdings Inc. Transaction History

Bayesian Capital Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$2.28 - $3.03 $683 - $908	300 Added 2.92%	10,584 $29,000
Q1 2024 May 15, 2024	SELL	$2.61 - $4.49 $15,138 - $26,042	-5,800 Reduced 36.06%	10,284 $29,000
Q4 2023 Feb 14, 2024	BUY	$1.97 - $4.21 $31,685 - $67,713	16,084 New	16,084 $65,000
Q2 2022 Aug 15, 2022	SELL	$4.74 - $8.15 $189,126 - $325,185	-39,900 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$6.47 - $9.57 $258,153 - $381,843	39,900 New	39,900 $304,000

117

63.2M

25K

23.2K

Ticker ORGO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 130,888,000
Market Cap $406M
Description
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Bayesian Capital Management, LP with notifications on news.